Tag: cell and gene therapy clinical trial services market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Cell And Gene Therapy Clinical Trial Services Market From 2025 To 2034?

The cell and gene therapy clinical trial services market size has experienced substantial growth in recent times. Projections indicate this market will expand from $3.79 billion in 2024 to reach $4.18 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by several factors, including the rising incidence of chronic diseases, a greater need for effective therapies for rare genetic disorders, enhanced government investment in regenerative medicine research, a deeper comprehension of the molecular mechanisms of various ailments, and a heightened recognition of personalized medicine’s promise.

The cell and gene therapy clinical trial services market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $6.02 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include the escalating global prevalence of genetic and auto-immune conditions, increased investment from both public and private sectors in gene therapy research, the expanding integration of new technologies, and an uptick in genetic defects. Key trends for the forecast period encompass the integration of AI, the utilization of machine learning, the implementation of personalized medicine, continuous technological advancements, and the development of new gene therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

What Are The Drivers Pushing New Developments In The Cell And Gene Therapy Clinical Trial Services Market?

The increasing prevalence of genetic conditions is anticipated to fuel expansion in the cell and gene therapy clinical trial services market in the future. These diseases stem from alterations in an individual’s DNA or genetic makeup. Several factors contribute to this rise, such as broader access to genetic screening, the emergence of genetic mutations, and the commonality of marriages between close relatives. To tackle the growing occurrence of genetic diseases, cell and gene therapy clinical trial services facilitate the creation of innovative treatments, customize therapies for specific patients, expedite the application of research into clinical settings, and broaden the therapeutic choices for those with genetic disorders. As an illustration, data from July 2022 by the Cystic Fibrosis (CF) Foundation, a US-based non-profit entity, indicated a notable increase in the population affected by cystic fibrosis. By 2022, nearly 40,000 children and adults in the United States were living with cystic fibrosis, with over 105,000 individuals diagnosed globally. Consequently, the escalating occurrence of genetic diseases is a key factor propelling the expansion of the cell and gene therapy clinical trial services market.

What Are The Major Segment Categories Driving The Cell And Gene Therapy Clinical Trial Services Market Growth?

The cell and gene therapy clinical trial servicesmarket covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services

2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy

3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection

How Are Trends Influencing The Cell And Gene Therapy Clinical Trial Services Market?

Leading companies in the cell and gene therapy clinical trial services market are dedicating resources to integrate advanced technology, particularly customer relationship management systems, to enhance efficiency and gain a competitive edge. The customer relationship management system employed by cell and gene therapy clinical trial services organizes and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the entire clinical trial process. For example, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, introduced the Cell and Gene Therapy (CGT) Integration Hub, a platform designed to improve connectivity and streamline processes across the cell and gene therapy treatment pathway. This platform, supported by AmerisourceBergen’s customer relationship management (CRM) system, aims to simplify the path-to-care process, partly by offering physicians and patient services teams increased visibility across the therapy development and delivery. Featuring capabilities such as expedited benefits investigation, real-time status tracking, and proactive alerts, the CGT Integration Hub endeavors to simplify care coordination, reduce impediments, and enhance the overall experience for both patients and providers involved in delivering cell and gene therapies.

Which Industry Leaders Are Driving Innovation Across The Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Geographies Are Emerging As Strong Markets For The Cell And Gene Therapy Clinical Trial Services Industry?

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell And Gene Therapy Clinical Trial Services Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Surface Marker Detection Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-surface-marker-detection-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Anticipated CAGR of the Cell And Gene Therapy Clinical Trial Services Market, and What Factors Will Drive It?#_x000D_

In the past few years, the market size for cell and gene therapy clinical trial services has seen tremendous growth. It is expected to increase from $3.79 billion in 2024 to $4.18 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this significant growth during the historical period include growing prevalence of chronic ailments, heightened demand for effective cures for uncommon genetic diseases, amplified government funding directed towards research in regenerative medicine, expanded comprehension of molecular mechanisms contributing to various diseases, and heightened consciousness about the potential advantages of personalized medicine._x000D_

_x000D_

Strong expansion is predicted for the cell and gene therapy clinical trial services market in the approaching years, with projections estimating it to reach a value of $6.02 billion in 2029, expanding at a compound annual growth rate (CAGR) of 9.5%. The growth expected during the forecast period can be linked to a surge in global instances of genetic and auto-immune diseases, increased funding from public and private sectors for gene therapy research, rising uptake of cutting-edge technologies, and an escalation in the number of genetic flaws. Key trends for the upcoming period include the integration of AI, machine learning, personalized medicine, technological advancements, and gene therapies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theCell And Gene Therapy Clinical Trial Services Market?#_x000D_

An increase in genetic diseases is set to boost the growth of the cell and gene therapy clinical trial services market in the coming period. Genetic ailments, caused by changes in an individual’s DNA or genetic makeup, are growing at a rapid pace for various reasons such as broader accessibility to genetic tests, the appearance of genetic mutations, and the widespread nature of consanguineous marriage. These clinical trial services for cell and gene therapy respond to the mounting prevalence of genetic diseases by promoting the creation of new treatments, personalizing treatments for each patient, quickening the application of research into clinical practice, and broadening the choices for those battling genetic disorders. For example, the Cystic Fibrosis (CF) Foundation, a non-profit organization based in the US, reported a surge in cystic fibrosis cases in July 2022. In the same year, nearly 40,000 children and adults in the US were affected by cystic fibrosis, and globally, over 105,000 individuals received a diagnosis. Thus, the surging rates of genetic diseases is fueling the growth of the cell and gene therapy clinical trial services market._x000D_

_x000D_

#What Segment Types Define the Cell And Gene Therapy Clinical Trial Services Market Structure?#_x000D_

The cell and gene therapy clinical trial servicesmarket covered in this report is segmented – _x000D_

_x000D_

1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services_x000D_

2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy_x000D_

3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications_x000D_

4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans _x000D_

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services _x000D_

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs) _x000D_

4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions _x000D_

5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring _x000D_

6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection_x000D_

_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Cell And Gene Therapy Clinical Trial Services Market?#_x000D_

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Cell And Gene Therapy Clinical Trial Services Market?#_x000D_

Leading businesses in the cell and gene therapy clinical trial services sector are prioritizing the deployment of innovative technologies, including customer relationship management system technology, to elevate efficiency and secure a market advantage. The customer relationship management system used by these clinical trial services enables streamlining and harmonizing of communications with trial participants, healthcare providers, and other engaged parties throughout the clinical trial process. As an example, AmerisourceBergen Corporation, a healthcare firm from the US, unveiled the Cell and Gene Therapy (CGT) Integration Hub in April 2023. This platform, whose launch aimed at enhancing connectivity and simplifying processes all through the cell and gene therapy treatment pathway, is supported by AmerisourceBergen’s CRM system. It mainly makes strides towards smoothening the path-to-care process, partially by providing doctors and patient care teams with better visibility over the therapy development and delivery process. The CGT Integration Hub, equipped with features such as quick benefits investigation, real-time status monitoring, and early warning alerts, intends to facilitate care coordination, lessen obstacles, and enhance the overall experience for both patients and providers while offering cell and gene therapies._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report_x000D_

_x000D_

#What Is the Definition of the Cell And Gene Therapy Clinical Trial Services Market?#_x000D_

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards. _x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Cell And Gene Therapy Clinical Trial Services Market In 2029?

The market size for clinical trial services in cell and gene therapy has experienced swift growth in recent years. It is projected to expand from $3.79 billion in 2024 to reach $4.2 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 10.7%. The acceleration in growth during this historic period is linked to factors such as the higher frequency of chronic ailments, rising demand for efficient treatments for uncommon genetic maladies, enhanced governmental funding for regenerative medicine research, improved comprehension of molecular procedures related to various diseases, and growing awareness about the prospects of personalized medicine.

What Growth Rate Is Forecasted for the Cell And Gene Therapy Clinical Trial Services Market by 2029?

Over the next few years, rapid expansion is anticipated in the market for cell and gene therapy clinical trial services. With a compound annual growth rate (CAGR) of 10.3%, the market is projected to reach $6.22 billion by 2029. The rise in genetic and auto-immune disease cases worldwide, increased funding by the public and private sectors for gene therapy research, new technology utilization, and a surge in genetic defects are all contributing factors to the growth during this forecast period. Key trends expected in this period include the use of artificial intelligence, machine learning adoption, personalized medicine, technological advancements, and gene therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

Which Key Companies Are Shaping the Future of the Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Which Factors Are Driving Demand in the Cell And Gene Therapy Clinical Trial Services Industry?

The growth of the cell and gene therapy clinical trial services market is anticipated to be driven by the increasing prevalence of genetic disorders. These disorders stem from changes in an individual’s DNA or genetic make-up. Factors contributing to the surge in genetic disorders include the rise in genetic testing availability, genetic mutations occurrence, and the high rate of consanguineous marriages. This rising trend of genetic diseases is being tackled by the cell and gene therapy clinical trial services market by promoting innovative treatment development, personalizing treatments for each patient, hastening research conversion into clinical applications, and broadening the treatment prospects for patients with genetic conditions. For example, the Cystic Fibrosis (CF) Foundation, a not-for-profit organization based in the US, reported a substantial increase in the cystic fibrosis affected population in July 2022. In 2022, approximately 40,000 children and adults in the US were affected by cystic fibrosis, and globally, over 105,000 people were diagnosed. Hence, the escalating prevalence of genetic disorders is fuelling the cell and gene therapy clinical trial services market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

How Is the Cell And Gene Therapy Clinical Trial Services Market Segmented by Several Divisions?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

What are the Emerging Market Trends Driving the Growth of the Cell And Gene Therapy Clinical Trial Services Industry?

Leading corporations in the cell and gene therapy clinical trial services market are diversifying their strategies by implementing cutting-edge technology and customer relationship management system technology to enhance productivity and gain an upper hand in the competitive market. The customer relationship management system used by these services enhances the communication and interaction with trial participants, healthcare providers, and other involved parties during the clinical trial phase. For example, in April 2023, AmerisourceBergen Corporation, a healthcare firm based in the US, inaugurated the Cell and Gene Therapy (CGT) Integration Hub. This platform aims to augment connectivity and simplify processes throughout the cell and gene therapy treatment journey. Supported by AmerisourceBergen’s customer relationship management (CRM) system, it aims to streamline the care pathway by offering physicians and patient services teams increased transparency throughout therapy development and delivery. The CGT Integration Hub, equipped with features such as fast-tracked benefits investigation, real-time status updates, and preemptive alerts, is designed to simplify care coordination, reduce obstacles, and enhance the experience for patients and providers throughout the delivery of cell and gene therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Regions Are Driving Growth in the Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

This Report Delivers Insight On:

1. How big is the cell and gene therapy clinical trial services market, and how is it changing globally?

2. Who are the major companies in the cell and gene therapy clinical trial services market, and how are they performing?

3. What are the key opportunities and risks in the cell and gene therapy clinical trial services market right now?

4. Which products or customer segments are growing the most in the cell and gene therapy clinical trial services market?

5. What factors are helping or slowing down the growth of the cell and gene therapy clinical trial services market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Cell And Gene Therapy Clinical Trial Services Market In 2029?

The market size for clinical trial services in cell and gene therapy has experienced swift growth in recent years. It is projected to expand from $3.79 billion in 2024 to reach $4.2 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 10.7%. The acceleration in growth during this historic period is linked to factors such as the higher frequency of chronic ailments, rising demand for efficient treatments for uncommon genetic maladies, enhanced governmental funding for regenerative medicine research, improved comprehension of molecular procedures related to various diseases, and growing awareness about the prospects of personalized medicine.

What Growth Rate Is Forecasted for the Cell And Gene Therapy Clinical Trial Services Market by 2029?

Over the next few years, rapid expansion is anticipated in the market for cell and gene therapy clinical trial services. With a compound annual growth rate (CAGR) of 10.3%, the market is projected to reach $6.22 billion by 2029. The rise in genetic and auto-immune disease cases worldwide, increased funding by the public and private sectors for gene therapy research, new technology utilization, and a surge in genetic defects are all contributing factors to the growth during this forecast period. Key trends expected in this period include the use of artificial intelligence, machine learning adoption, personalized medicine, technological advancements, and gene therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

Which Key Companies Are Shaping the Future of the Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Which Factors Are Driving Demand in the Cell And Gene Therapy Clinical Trial Services Industry?

The growth of the cell and gene therapy clinical trial services market is anticipated to be driven by the increasing prevalence of genetic disorders. These disorders stem from changes in an individual’s DNA or genetic make-up. Factors contributing to the surge in genetic disorders include the rise in genetic testing availability, genetic mutations occurrence, and the high rate of consanguineous marriages. This rising trend of genetic diseases is being tackled by the cell and gene therapy clinical trial services market by promoting innovative treatment development, personalizing treatments for each patient, hastening research conversion into clinical applications, and broadening the treatment prospects for patients with genetic conditions. For example, the Cystic Fibrosis (CF) Foundation, a not-for-profit organization based in the US, reported a substantial increase in the cystic fibrosis affected population in July 2022. In 2022, approximately 40,000 children and adults in the US were affected by cystic fibrosis, and globally, over 105,000 people were diagnosed. Hence, the escalating prevalence of genetic disorders is fuelling the cell and gene therapy clinical trial services market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

How Is the Cell And Gene Therapy Clinical Trial Services Market Segmented by Several Divisions?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

What are the Emerging Market Trends Driving the Growth of the Cell And Gene Therapy Clinical Trial Services Industry?

Leading corporations in the cell and gene therapy clinical trial services market are diversifying their strategies by implementing cutting-edge technology and customer relationship management system technology to enhance productivity and gain an upper hand in the competitive market. The customer relationship management system used by these services enhances the communication and interaction with trial participants, healthcare providers, and other involved parties during the clinical trial phase. For example, in April 2023, AmerisourceBergen Corporation, a healthcare firm based in the US, inaugurated the Cell and Gene Therapy (CGT) Integration Hub. This platform aims to augment connectivity and simplify processes throughout the cell and gene therapy treatment journey. Supported by AmerisourceBergen’s customer relationship management (CRM) system, it aims to streamline the care pathway by offering physicians and patient services teams increased transparency throughout therapy development and delivery. The CGT Integration Hub, equipped with features such as fast-tracked benefits investigation, real-time status updates, and preemptive alerts, is designed to simplify care coordination, reduce obstacles, and enhance the experience for patients and providers throughout the delivery of cell and gene therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Regions Are Driving Growth in the Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

This Report Delivers Insight On:

1. How big is the cell and gene therapy clinical trial services market, and how is it changing globally?

2. Who are the major companies in the cell and gene therapy clinical trial services market, and how are they performing?

3. What are the key opportunities and risks in the cell and gene therapy clinical trial services market right now?

4. Which products or customer segments are growing the most in the cell and gene therapy clinical trial services market?

5. What factors are helping or slowing down the growth of the cell and gene therapy clinical trial services market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cell and gene therapy clinical trial services industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Cell And Gene Therapy Clinical Trial Services Market, and What Factors Will Drive It?

The market for cell and gene therapy clinical trial services have experienced swift expansion in the past few years. The increase from $3.79 billion in 2024 to $4.2 billion in 2025 is expected, reflecting a compound annual growth rate (CAGR) of 10.7%. The historic rise can be linked to the growing incidences of chronic illnesses, heightened need for effective treatments for rare genetic disorders, enhanced government support for regenerative medicine research, improved comprehension of molecular mechanisms related to several diseases and a raised consciousness about the capabilities of personalized medicine.

The market size of clinical trial services for cell and gene therapy is anticipated to witness significant growth in the ensuing years. It is projected to reach $6.22 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.3%. The growth for the prediction period is linked to the rising worldwide prevalence of genetic and auto-immune diseases, increased funding for gene therapy research from both the public and private sectors, wider acceptance of groundbreaking technologies and an increase in the count of genetic defects. Key trends during the forecasted period encompass the incorporation of AI, the implementation of machine learning, the introduction of customized medicine, technological advancements, as well as gene therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

What Are the Core Market Drivers Propelling Growth in the Cell And Gene Therapy Clinical Trial Services Industry?

The escalation in cases of genetic disorders is forecasted to spur the expansion of the cell and gene therapy clinical trial services market. Genetic disorders are conditions brought on by alterations in an individual’s DNA or genetic make-up. Several reasons, including the increasing accessibility of genetic testing, the appearance of genetic mutations, and the commonality of consanguineous marriages are responsible for the surge in genetic diseases. Cell and gene therapy clinical trial services aim to address the escalation of genetic disorders by promoting the creation of innovative treatments, personalizing therapies for each patient, expediting the application of research into clinical use, and broadening the selection of treatments for those affected by genetic ailments. For instance, the Cystic Fibrosis (CF) Foundation, a non-profit organization based in the US, reported a surge in cystic fibrosis cases in July 2022. In 2022, cystic fibrosis impacted nearly 40,000 children and adults in the United States, and over 105,000 people globally have been diagnosed. Consequently, the escalation in genetic disorders is contributing to the expansion of the cell and gene therapy clinical trial services market.

How Is the Cell And Gene Therapy Clinical Trial Services Market Segmented?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Which Regions Are Driving the Next Phase of the Cell And Gene Therapy Clinical Trial Services Market Growth?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Cell And Gene Therapy Clinical Trial Services Market Over the Coming Years?

Leading enterprises in the cell and gene therapy clinical trial services market are directing their resources towards the incorporation of high-tech customer relationship management system technology to enhance efficiency and gain a competitive advantage. The cell and gene therapy clinical trial services use these systems to efficiently coordinate and manage interactions with trial participants, healthcare providers, and other involved parties throughout the clinical trial procedure. For example, in April 2023, the US healthcare company AmerisourceBergen Corporation launched the Cell and Gene Therapy (CGT) Integration Hub. This platform, designed to improve connectivity and streamline operations throughout the cell and gene therapy treatment pathway, is powered by AmerisourceBergen’s CRM system. Its aim is to simplify the journey to treatment by providing physicians and patient services teams with a clearer picture of the therapy development and delivery process. The CGT Integration Hub, which comes with features like accelerated benefits investigation, real-time status tracking, and proactive alerts, aspires to simplify care coordination, reduce obstacles, and enhance the overall experience of patients and providers when administering cell and gene therapies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

How Is the Cell And Gene Therapy Clinical Trial Services Market Defined and What Are Its Core Parameters?

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theCell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial services market is set to be propelled by the increasing occurrence of genetic diseases. These include conditions arising from variations in an individual’s genetic makeup or DNA. The surge in genetic diseases can be attributed to multiple reasons such as greater accessibility to genetic testing, instances of genetic mutations, and the prominence of marriages between close relatives. To address the mounting prevalence of genetic diseases, cell and gene therapy clinical trial services are promoting the creation of new treatments, adjusting therapies to suit individual patients’ needs, hastening the conversion of research into clinical applications and broadening the choices for patients with genetic disorders. For example, in July 2022, the Cystic Fibrosis (CF) Foundation, a not-for-profit organization based in the United States, reported a hike in the prevalence of people suffering from cystic fibrosis; around 40,000 children and adults in the United States and more than 105,000 people worldwide were affected by the disease in 2022. Thus, the rising occurrence of genetic diseases is fuelling the expansion of the cell and gene therapy clinical trial services market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

#What is the Anticipated CAGR of theCell And Gene Therapy Clinical Trial Services Market, and What Factors Will Drive It?

Over the past few years, the market size for clinical trial services for cell and gene therapy has seen a significant increase. The forecast suggests a rise from $3.79 billion in 2024, up to $4.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%. The prior growth can be attributed to factors such as the rising prevalence of long-term illnesses, heightened demand for efficacious treatments for rare genetic disorders, better government funding for regenerative medicine research, improved comprehension of the molecular mechanisms involved in various diseases, and enhanced recognition of personalized medicine’s potential.

Expected to see a fast-paced expansion in the coming years, the market for cell and gene therapy clinical trial services is envisaged to reach a valuation of $6.22 billion in 2029, with a compound annual growth rate (CAGR) of roughly 10.3%. This growth over the predicted period can be ascribed to factors such as the escalating global occurrence of genetic and auto-immune diseases, the rise in public as well as private sector investment in gene therapy research, increased acceptance of new technologies, and a surge in the number of genetic defects. Key trends in the forecast phase encompass the incorporation of AI, the use of machine learning, the application of personalized medicine, technological advancements, and gene therapies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

What Key Market Trends and Innovations Are Shaping the Future of theCell And Gene Therapy Clinical Trial Services Industry?

Leading companies in the cell and gene therapy clinical trial services market are turning to sophisticated technology integrated with customer relationship management (CRM) systems in order to enhance their operational efficiency and secure a competitive edge. These CRM systems deployed by cell and gene therapy clinical trial services enhance coordination and streamline communication with trial participants, healthcare providers, and other relevant parties during the clinical trial process. For example, in April 2023, the healthcare firm AmerisourceBergen Corporation, based in the US, unveiled the Cell and Gene Therapy (CGT) Integration Hub. This platform is designed to boost connectivity and streamline procedures throughout the cell and gene therapy treatment pathway. Backed by AmerisourceBergen’s CRM system, the platform aims to simplify the path-to-care by providing doctors and patient services teams with improved oversight of the therapy development and delivery process. The CGT Integration Hub, equipped with features such as expedited benefits investigation, real-time status tracking, and proactive alerts, is designed to simplify care coordination, eliminate hurdles, and enhance the overall experience of patients and providers in the delivery of cell and gene therapies.

Which Companies Are Leading the Charge in Expanding theCell And Gene Therapy Clinical Trial Services Market Growth?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

How is the Global Cell And Gene Therapy Clinical Trial Services Market Segemented?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Which Geographics are Influencing the Growth of the Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company:

Cell Isolation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-isolation-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Lysis And Fractionation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cell and gene therapy clinical trial services market grown in recent years?

The cell and gene therapy clinical trial services market has seen rapid growth in recent years. It will grow from $3.79 billion in 2024 to $4.2 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%. This growth is driven by the rising prevalence of chronic diseases, the demand for treatments for rare genetic disorders, increased funding for regenerative medicine research, better understanding of molecular disease mechanisms, and the increasing recognition of personalized medicine.

How is the cell and gene therapy clinical trial services market size expected to evolve during the forecast period?

The cell and gene therapy clinical trial services market is expected to reach $6.22 billion by 2029 with a CAGR of 10.3%. Growth is driven by the rise in genetic and autoimmune diseases, increased funding for gene therapy, the adoption of novel technologies, and growing genetic defects. Trends include AI and machine learning adoption, personalized medicine, and advancements in gene therapies.

Get your cell and gene therapy clinical trial services market report here!

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which key drivers are propelling the cell and gene therapy clinical trial services market’s growth?

The rising incidence of genetic diseases is expected to drive the growth of the cell and gene therapy clinical trial services market. Genetic diseases are caused by variations in DNA or genetic composition, and their prevalence is rising due to factors like increased genetic testing and consanguineous marriages. Clinical trial services for cell and gene therapies are key in developing new treatments for genetic disorders. For example, in July 2022, the Cystic Fibrosis Foundation reported that cystic fibrosis affects nearly 40,000 people in the U.S., and over 105,000 people globally. The growing incidence of genetic diseases is propelling the market forward.

What are the market segments in the cell and gene therapy clinical trial services industry?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

Which leading companies are shaping the growth of the cell and gene therapy clinical trial services market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

What key trends are currently impacting the cell and gene therapy clinical trial services market’s development?

In the cell and gene therapy clinical trial services market, companies are implementing advanced technologies, such as customer relationship management (CRM) systems, to streamline processes and improve efficiency. For example, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, launched the Cell and Gene Therapy (CGT) Integration Hub, which leverages CRM technology to enhance connectivity and simplify the therapy development process. The platform aims to improve patient and provider experiences by offering real-time tracking, expedited benefits investigation, and proactive alerts.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

Which geographic areas are influencing the growth of the cell and gene therapy clinical trial services market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell Isolation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-isolation-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Lysis And Fractionation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Cell And Gene Therapy Clinical Trial Services Market Shape Industry Trends by 2034?

There has been impressive growth in recent years in the market size of clinical trial services for cell and gene therapy. The market, which will expand from $3.79 billion in 2024 to $4.2 billion in 2025, is expected to witness a compound annual growth rate (CAGR) of 10.7%. This growth during the historic period can be traced back to an elevated incidence of chronic diseases, a heightened demand for successful treatments for rare genetic conditions, an increase in government funding towards regenerative medical research, an expanded comprehension of the molecular mechanisms of various diseases, and enhanced awareness in personalized medicine’s potential.

The market size of clinical trial services for cell and gene therapy is projected to undergo significant expansion in the coming years, anticipated to reach $6.22 billion by 2029, with a compound annual growth rate (CAGR) of 10.3%. This predicted growth during the projection period is due to the surge in worldwide cases of genetic and autoimmune diseases, increasing funds from the public and private sectors towards gene therapy research, the uptake of groundbreaking technologies, and an increase in genetic defects. Emerging trends within the forecast period consist of the integration of Artificial Intelligence, the employment of machine learning, the adoption of personalized medication, technological progressions, and gene therapies.

What Are the Primary Drivers Supporting the Growth of the Cell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial services market growth is set to be spurred on by the escalating incidence of genetic diseases. These diseases are triggered by alterations in an individual’s DNA or genetic makeup. Various factors, such as increased genetic testing availability, the frequency of genetic mutations, and commonality of consanguineous marriages, are behind the rising prevalence of these diseases. The market for cell and gene therapy clinical trial services responds to this surge by fostering the creation of innovative treatments, personalizing therapies to each patient, hastening the conversion of research into clinical application, and widening the choices for patients plagued by genetic disorders. For instance, the Cystic Fibrosis (CF) Foundation, a not-for-profit organization based in the USA, reported a significant rise in cystic fibrosis cases in July of 2022. The disease affected close to 40,000 children and adults in the United States in 2022, with the global count exceeding 105,000 diagnosed cases. Therefore, the escalating incidence of genetic diseases is fueling the expansion of the cell and gene therapy clinical trial services market.

Request Your Free Cell And Gene Therapy Clinical Trial Services Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

Who Are the Key Market Players Influencing the Growth of the Cell And Gene Therapy Clinical Trial Services Industry?

Major companies operating in the cell and gene therapy clinical trial services market are:

• Thermo Fisher Scientific Inc.

• Sharp Services LLC

• IQVIA

• Laboratory Corporation of America Holdings

• ICON plc

What Key Market Trends Are Shaping the Future of the Cell And Gene Therapy Clinical Trial Services Industry?

Noteworthy corporations within the cell and gene therapy clinical trial services market are directing their resources towards implementing sophisticated technology inclusive of customer relationship management system technology. This strategy aims to boost efficiency and secure a competitive edge in the market. The customer relationship management system adopted by these services optimizes and orchestrates communications with trial participants, healthcare providers, and other stakeholders throughout the clinical trial course. For example, AmerisourceBergen Corporation, a healthcare firm based in the US, unveiled the Cell and Gene Therapy (CGT) Integration Hub in April 2023. This platform seeks to enhance connectivity and expedite processes across the treatment pathway of cell and gene therapy. It is supported by AmerisourceBergen’s customer relationship management (CRM) system and aims to streamline the path-to-care process by extending superior visibility to doctors and patient services teams over the therapy development and delivery process. The CGT Integration Hub, equipped with features like accelerated benefits investigation, real-time status tracking, and proactive alerts, aspires to simplify care coordination, reduce hurdles, and enhance the overall patient and provider experience in delivering cell and gene therapies.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Cell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

Which Regions Are Emerging as Leaders in the Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Cell And Gene Therapy Clinical Trial Services Market?

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards.

Browse Through More Similar Reports By The Business Research Company:

Cell Isolation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-isolation-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Lysis And Fractionation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: